MedTrace Logo

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial

NCT07013981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-06-10

No results posted yet for this study

Summary

The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.

Conditions

  • Depressive Symptoms

Interventions

DIETARY_SUPPLEMENT

Omega-3 polyunsaturated fatty acids

DIETARY_SUPPLEMENT

Omega-3 polyunsaturated fatty acids

Sponsors & Collaborators

  • Japanese Society for the Promotion of Science

    collaborator OTHER

  • University of Toyama

    collaborator OTHER

  • Chiba University

    collaborator OTHER

  • National Science and Technology Council, Taiwan

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-09
Primary Completion
2017-05-11
Completion
2017-11-11

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07013981 on ClinicalTrials.gov